お知らせ • Aug 16
TB SA Acquisition Corp announced delayed 10-Q filing On 08/15/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Jun 10
TB SA Acquisition Receives Non-Compliance Letter from Nasdaq On June 1, 2022, TB SA Acquisition Corp. (the Company") received a deficiency letter from The Nasdaq Stock Market LLC (Nasdaq") indicating that it was not in compliance with Section 5250(c) of Nasdaq Rules regarding theQualification, Listing and Delisting of Companies (the Nasdaq Listing Rules") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the Form 10-Q") with the Securities and Exchange Commission (the SEC") through the SEC's EDGAR System. On May 16, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the Form 12b-25"), indicating that the filing of its Form 10-Q will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to complete and file the Form 10-Q prior to May 21, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Quarterly Report. Under the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. お知らせ • May 17
TB SA Acquisition Corp announced delayed 10-Q filing On 05/16/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Apr 26
TB SA Acquisition Corp Announces Receipt of NASDAQ Continued Listing Standard Notice TB SA Acquisition Corp. announced that on April 19, 2022 it received a deficiency letter from The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On April 1, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 15, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-K in order to ensure a complete, accurate Annual Report. The delay is due primarily to additional information and investigation needed in relation to the Company’s financial statements to complete the audit. In the course of its audit, the Company identified material weaknesses in its internal control over financial reporting related to its accounting for complex financial instruments and over the evaluation of vesting terms and recording of stock compensation expense. This further determination and related work and procedures resulted in the Company requiring additional time beyond the 15-day period provided by Rule 12b-25 to complete and file the Form 10-K. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has until 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules. The Company intends to submit the Compliance Plan as soon as practicable. The Company is in compliance with all other Nasdaq continued listing standards. The Company expects to file the Form 10-K in the very near term and does not foresee any risk of non-compliance with the Nasdaq 60-day remediation timeframe. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. お知らせ • Apr 03
TB SA Acquisition Corp announced delayed annual 10-K filing On 04/01/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC. お知らせ • Aug 14
TB SA Acquisition Corp announced delayed 10-Q filing On 08/13/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • May 19
TB SA Acquisition Corp announced delayed 10-Q filing On 05/18/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.